Powered by: Motilal Oswal
20/07/2023 10:14:55 AM | Source: Accord Fintech
SecureKloud Technologies surges as its arm secures multi-year program expansion contract
News By Tags | #6140 #7176 #409 #7887 #572

Securekloud Technologies is currently trading at Rs. 46.58, up by 2.09 points or 4.70% from its previous closing of Rs. 44.49 on the BSE.

The scrip opened at Rs. 46.49 and has touched a high and low of Rs. 46.71 and Rs. 45.15 respectively. So far 5541 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 81.50 on 22-Jul-2022 and a 52 week low of Rs. 30.06 on 02-May-2023.

Last one week high and low of the scrip stood at Rs. 51.64 and Rs. 43.76 respectively. The current market cap of the company is Rs. 148.64 crore.

The promoters holding in the company stood at 43.52%, while Institutions and Non-Institutions held 0.02% and 56.46% respectively.

SecureKloud Technologies’ step-down subsidiary -- Healthcare Triangle Inc has secured a multi-year program expansion contract with a top-five customer, a Fortune 500 biopharmaceutical company. The agreement extends the customer’s suite of cloud DevOps, data engineering, and data platform management solutions. 

Healthcare Triangle advances industry-transforming solutions in the areas of cloud services, data science, cyber security and professional and managed services for the healthcare and life sciences industries. The Company is strategically partnered with leading public cloud providers including Amazon Web Services, Google Cloud, Microsoft Azure Cloud, and EHR vendors.

SecureKloud Technologies is a cloud native company with a combination of products, frameworks and services, designed to solve problems around Blockchain, Cloud, Enterprise Security, Decision Engineering and Managed Services.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here